Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
JCI Insight
|
May 13, 2020
Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis
Andrea Fava, Jill Buyon, Chandra Mohan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 16, 2021
Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis
Andrea Fava, Deepak A Rao, Chandra Mohan, et al.
Arthritis Care & Research
|
April 28, 2026
Clinical, histological, and serological predictors of renal function loss in lupus nephritis
Shangzhu Zhang, Laurence Magder, Daniel Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Lupus Science & Medicine
|
August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network
Kristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
JCI Insight
|
January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
Andrea Fava, Jill Buyon, Laurence Magder, et al.
ACR Open Rheumatology
|
November 26, 2025
Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
Hassan Kawtharany, April Jorge, Muayad Azzam, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
JCI Insight
|
May 13, 2020
Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis
Andrea Fava, Jill Buyon, Chandra Mohan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 16, 2021
Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis
Andrea Fava, Deepak A Rao, Chandra Mohan, et al.
Arthritis Care & Research
|
April 28, 2026
Clinical, histological, and serological predictors of renal function loss in lupus nephritis
Shangzhu Zhang, Laurence Magder, Daniel Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Lupus Science & Medicine
|
August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network
Kristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
JCI Insight
|
January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
Andrea Fava, Jill Buyon, Laurence Magder, et al.
ACR Open Rheumatology
|
November 26, 2025
Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
Hassan Kawtharany, April Jorge, Muayad Azzam, et al.
Page
of 8